22.25INR
4.71 BINR
61.97 BINR
127.36 M
About IPCA LABORATORIES
Sector
Headquarters
Mumbai
Employees (FY)
21.31 K
Website
Founded
1949
ISIN
INE571A01038
FIGI
BBG000D4LR21
Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.
Keep An Eye - IPCALAB📊 Script: IPCALAB
📊 Sector: Pharmaceuticals
📊 Industry: Pharmaceuticals - Indian - Bulk Drugs
Key highlights: 💡⚡
📈 Keep An Eye on Script, it is trading near its resistance level which is 1248 and may give breakout of it.
📈 Script is trading at upper band of BB.
📈 MACD is giving crossover.
📈
IPCA lab31/03/2024
IPCA lab on monthly chart
BO above 1385
SL : As per your risk
Target : 10 to 20 % above BO
Information is only for study purpose
Ipcalab , a pharmaceutical company Ipcalab , a pharmaceutical company, is currently positioned at its Fibonacci reversal levels, indicating a potential turning point in its price action. Following bullish signals, the stock is expected to trade within the range of 1320 to 1350. This suggests a positive sentiment among investors, with
#IPCALAB Stock looks good for another 20-25% move above. #IPCALAB
Stock looks good for another 20-25% move above.
A candle close below ₹1100 would trigger me to close the position.
1) There is a bullish pennant forming with measured target of above ₹1400
2) Horizontal previous ATH support - Looks great.
Bullish Flag in IPCA lab- Action continuesAbout IPCA laboratories
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai, India. It was founded in 1949 by a group of businessmen and medical professionals. The company manufactures and markets a wide range of pharmaceutical products, including active phar
💥IPCA Labs💥-Nice Breakout💥IPCA Labs💥-Nice Breakout
Capital to be deployed- 20k
Investing Price -1020-1040
Breakout Price-1006
Stoploss-934
Targets-1144-1353-1678
RT for max reach
#ipca #StocksToBuy #stocks #StocksToTrade #StocksInFocus #stockstowatch #StocksInNews
IPCALAB:- Resistance BreakoutIPCALAB has given a resistance breakout with high volume, so there is a very high chance that it will continue to rally upward.
Entry Above @1015 looks good and stops Loss Below @950
Possibilities of IPCALABNSE:IPCALAB Stock currently break her resistance and also retracement complete, take position for first target of 1005 and stop loss is 925. Risk reward is 1:3
I am not SEBI registered, I am not responsible for any of your Profit/loss with this channel's suggestion. Please Consult your financial
ipca lab strong buy completed its retracement and going very aggressively to break 950 levels very soon.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IPCALAB is 1352.30 INR — it has increased by 0.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange IPCA LABORATORIES stocks are traded under the ticker IPCALAB.
IPCA LABORATORIES is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
IPCALAB stock is 2.97% volatile and has beta coefficient of −0.10. Check out the list of the most volatile stocks — is IPCA LABORATORIES there?
One year price forecast for IPCA LABORATORIES has a max estimate of 1505.00 INR and a min estimate of 910.00 INR.
IPCALAB earnings for the last quarter are 5.70 INR whereas the estimation was 7.17 INR which accounts for −20.47% surprise. Estimated earnings for the next quarter are 6.00 INR. See more details about IPCA LABORATORIES earnings.
IPCA LABORATORIES revenue for the last quarter amounts to 20.34 B INR despite the estimated figure of 17.27 B INR. In the next quarter revenue is expected to reach 20.96 B INR.
Yes, you can track IPCA LABORATORIES financials in yearly and quarterly reports right on TradingView.
IPCALAB stock has risen by 1.68% compared to the previous week, the month change is a 16.47% rise, over the last year IPCA LABORATORIES has showed a 61.95% increase.
IPCALAB net income for the last quarter is 1.80 B INR, while the quarter before that showed 1.45 B INR of net income which accounts for 24.00% change. Track more IPCA LABORATORIES financial stats to get the full picture.
Today IPCA LABORATORIES has the market capitalization of 340.43 B, it has increased by 5.14% over the last week.
IPCA LABORATORIES dividend yield was 0.49% in 2022, and payout ratio reached 21.53%. The year before the numbers were 0.38% and 11.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, IPCALAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IPCA LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 21.31 K employees. See our rating of the largest employees — is IPCA LABORATORIES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IPCA LABORATORIES technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IPCA LABORATORIES stock shows the strong buy signal. See more of IPCA LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IPCA LABORATORIES future price: according to them, IPCALAB price has a max estimate of 1505.00 INR and a min estimate of 910.00 INR. Read a more detailed IPCA LABORATORIES forecast: see what analysts think of IPCA LABORATORIES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IPCA LABORATORIES EBITDA is 11.81 B INR, and current EBITDA margin is 16.02%. See more stats in IPCA LABORATORIES financial statements.